Oncotelic Therapeutcs Inc (OTLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,898 | -2,239 | 249,025 | -1,268 | -154 |
| Depreciation Amortization | 302 | 146 | 198 | 136 | 81 |
| Income taxes - deferred | N/A | N/A | 111,550 | N/A | N/A |
| Accounts payable and accrued liabilities | 1 | -166 | 2 | 2 | 1 |
| Other Working Capital | 22 | -161 | 106 | 382 | 204 |
| Other Operating Activity | 1,139 | 2,078 | -362,265 | 150 | -426 |
| Operating Cash Flow | $-434 | $-342 | $-1,383 | $-600 | $-293 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 58 | 17 | 908 | 445 | 295 |
| Debt Issued | 500 | 350 | 478 | 478 | N/A |
| Common Stock Issued | 7 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -33 | -50 | 0 | 0 | 0 |
| Financing Cash Flow | $532 | $317 | $1,386 | $923 | $295 |
| Beginning Cash Position | 109 | 109 | 106 | 106 | 106 |
| End Cash Position | 206 | 84 | 109 | 429 | 108 |
| Net Cash Flow | $97 | $-25 | $3 | $323 | $2 |
| Free Cash Flow | |||||
| Operating Cash Flow | -434 | -342 | -1,383 | -600 | -293 |
| Free Cash Flow | -434 | -342 | -1,383 | -600 | -293 |